foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Investor interview with Mark Barnett

Biotech and Money recently caught up with Mark Barnett, Head of UK Equities...

Read More

6 things we learned from Manuel llobet, CEO of All...

Biotech and Money recently had the opportunity to speak to Manuel Llobet, C...

Read More

AXA Framlington IM UK and the AXA Biotechnology Fu...

AXA Investment Managers, one of the world’s largest asset managers, offers ...

Read More

View of an active private life science investor

In March, Jon Moulton increased his shareholding in Redx Pharma as the biot...

Read More

ISSUE 3, 2015 Drugs & Dealers Magazine Released

The October issue of Drugs & Dealers is now available to VIEW the Magazine ...

Read More

Top tips on raising capital and 3 warning signs yo...

Biotech and Money caught up with one of the leading life science analysts i...

Read More

Weekly Poll#4: The cost of capital for early‐stage...

  This is the fourth of 4 weekly Polls hosted throughout July that will acc...

Read More

Weekly Poll #3: Where have you recently accessed s...

This is the third of 4 weekly Polls hosted throughout July that will accomp...

Read More

3 routes to access funding, and 1 simple way to ta...

Eddie Blair, CEO, GeneFirst, a biotech in the business of modernising molec...

Read More

1 Simple thing biotechs need to know to attract VC...

Finding VC capital for your early stage biotech is not easy. I’ve been aski...

Read More

Top tip on how biotechs can attract investors

I interviewed Malcom Young, CEO, e-therapeutics and asked him his secret to...

Read More

Add Your Response